You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 27, 2025

Drug Price Trends for NDC 70677-0046


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 70677-0046

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Market Analysis and Price Projections for the Drug NDC: 70677-0046

Understanding the National Drug Code (NDC)

To analyze the market and project prices for a specific drug identified by its NDC, it is crucial to understand what the NDC represents. The National Drug Code (NDC) is a unique, three-segment number that identifies the labeler, product, and trade package size of a drug. This code is essential for tracking and managing drug products in the U.S. market[1][5].

Identifying the Drug

The NDC 70677-0046 is associated with a specific drug product. However, without the exact name of the drug, we must rely on general principles of market analysis and pricing trends in the pharmaceutical industry.

Market Trends in the Pharmaceutical Industry

Pricing and Access

Pricing and access to drugs are significant issues in the life sciences industry. Executives in the sector expect these factors to significantly impact their strategies, with nearly half anticipating a major impact on their business in 2025[3].

Competition from Generics and Biosimilars

Competition from generic drugs and biosimilars is a top trend, with 37% of respondents viewing it as a key issue. This competition can drive down prices, especially as patents expire. For instance, the biopharma industry faces a substantial loss of exclusivity, with over $300 billion in sales at risk through 2030 due to expiring patents[3].

Price Transparency and Regulation

Price transparency programs highlight the variability in drug pricing. For example, the median price increase for generic drugs was 20%, while brand name drugs saw a median increase of 14.9% in recent reports. The quality of information submitted by manufacturers varies, making it challenging to determine the reasons behind high prices or price increases[4].

Pricing Dynamics

Wholesale Acquisition Cost (WAC)

The Wholesale Acquisition Cost (WAC) is a critical metric in drug pricing. It represents the list price of a drug before any discounts or rebates. For example, the highest WAC for a brand name drug reported recently was $3.5 million for Hemgenix, a treatment for hemophilia B[4].

Impact of Competition

Competition, especially from generic drugs, can significantly reduce prices. For instance, the WAC price for generic fingolimod was reduced by 84% to 97% from its starting price due to competition in the generics market[4].

Projecting Prices for NDC 70677-0046

Current Pricing

To project prices, one would typically start by identifying the current pricing of the drug associated with NDC 70677-0046. This involves looking at the current WAC, any recent price changes, and the pricing trends for similar drugs in the market.

Market Forces

  • Competition: If the drug faces competition from generics or biosimilars, prices are likely to decrease over time.
  • Regulatory Environment: Changes in regulatory requirements or transparency laws can impact pricing strategies.
  • Innovation and Patent Status: If the drug is nearing patent expiration, prices may drop as generic versions enter the market.

Example Scenario

If the drug associated with NDC 70677-0046 is a brand name drug with a current WAC of $100 per unit, and it is nearing patent expiration, we might expect the following:

  • Short-term: Prices may remain stable or see a moderate increase (e.g., 10-15%) due to market demand and the lack of immediate generic competition.
  • Long-term: As generic versions enter the market, prices could drop significantly (e.g., 50-70%) due to increased competition.

Key Takeaways

  • NDC Importance: The NDC is crucial for identifying and tracking drug products.
  • Market Trends: Pricing and access, competition from generics and biosimilars, and regulatory transparency are key factors influencing drug prices.
  • Price Projections: Prices can fluctuate based on competition, regulatory changes, and patent status.
  • Competition Impact: Generic competition can significantly reduce drug prices.

FAQs

1. What is the National Drug Code (NDC)? The National Drug Code (NDC) is a unique, three-segment number that identifies the labeler, product, and trade package size of a drug.

2. How does competition from generics affect drug prices? Competition from generics can significantly reduce drug prices. For example, the WAC price for generic fingolimod was reduced by 84% to 97% due to competition in the generics market[4].

3. What role does the FDA play in drug pricing? The FDA does not directly set drug prices but ensures that drugs are listed and reported correctly through the NDC Directory. Regulatory transparency programs can influence pricing by requiring manufacturers to provide detailed information about price increases[1][5].

4. How do patent expirations impact drug prices? Patent expirations can lead to the entry of generic versions, which typically results in a significant reduction in prices as competition increases[3].

5. What is the Wholesale Acquisition Cost (WAC)? The Wholesale Acquisition Cost (WAC) is the list price of a drug before any discounts or rebates. It is a critical metric in understanding the pricing dynamics of pharmaceuticals[4].

Sources

  1. FDA: National Drug Code Database Background Information
  2. Missouri Department of Social Services: MISSOURI SPECIALTY MAC NAME OF DRUG Strength NDC Price Effective January 1, 2023
  3. Deloitte Insights: 2025 life sciences outlook
  4. Oregon Department of Consumer and Business Services: Prescription Drug Price Transparency Program results and annual report 2023
  5. FDA: National Drug Code Directory

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.